Ranked by how strong the human evidence is — best supported first.
Best supportedDigestive comfortNot enough evidence· no source yetThen, in order
Chains of galactose units produced enzymatically from lactose. They resemble the oligosaccharides in human milk more closely than fructans do, which is why they are used in infant formula.
GOS is the prebiotic with the most interesting biological rationale, because human milk oligosaccharides are the archetype of a compound the infant cannot digest and the infant’s bifidobacteria can. Commercial GOS is not the same molecule but occupies the same niche, and it is bifidogenic at doses around 3–5 g/day — lower than inulin needs. The human outcome literature is small: a few trials on travellers’ diarrhoea, some on anxiety and cortisol awakening response that are frequently overstated, and a body of infant formula work. It is generally better tolerated than fructans at equivalent doses.
Regulation: Permitted in infant formula in the EU and elsewhere, usually in a 9:1 blend with fructooligosaccharides. Sold as a food supplement with no pre-market efficacy review and no authorised health claim.
The amounts, forms and durations published trials of Galactooligosaccharides (GOS) actually administered.
These are the amounts published trials administered — not a recommendation, and not a dose to copy. Trial participants were screened, supervised and given a characterised preparation. What is in a retail bottle is frequently not what was studied, and the amount that suits one person is not general advice.
Studied for Raising faecal bifidobacteria
2.5–5.5 g
GOS daily · 1–3 weeks
The bifidogenic effect appears at lower doses than for inulin. Most of this work uses one commercial preparation and was supported by its manufacturer.
Studied for Travellers’ diarrhoea
5.5 g
GOS daily, started before travel · 1 week before and during travel
From a small manufacturer-supported trial reporting reduced incidence and duration. It has not been independently replicated.
This is general information about food, not medical advice. It cannot diagnose, treat or replace guidance from a clinician who knows your history.
Each window says whether a trial compared it against an alternative, or whether it is convention and pharmacology. Most timing advice is the second kind.
None of the timings below were directly compared in a trial. They reflect how the research happened to dose, or what the pharmacology implies — which is not the same as a timing being better.
Usually taken once daily with food. No timing comparison has been published, and GOS does not depend on gastric survival because it is a carbohydrate rather than an organism.
Timing was not directly compared. This reflects convention or how the compound behaves in the body, not a trial showing this window works better.
What each association actually rests on, and the papers behind it. A rating describes the state of the research, not how promising the supplement sounds. How we rate evidence.
GOS is generally better tolerated than fructans and some trials report improved symptoms in irritable bowel syndrome at low doses, while higher doses worsen them. It remains a FODMAP.
Not enough evidence. Not enough human research to say anything useful yet.
Controlled trials show GOS increases faecal bifidobacteria at doses from about 2.5 g/day, with effects appearing within a week. Much of this work comes from one manufacturer, and the microbial change is not itself a health outcome.
Not enough evidence. Not enough human research to say anything useful yet.
A small trial reported a reduced cortisol awakening response and altered attentional bias to negative words after three weeks of GOS. This is a laboratory endpoint in a few dozen healthy volunteers, and there is not enough evidence to support an anxiety claim.
Not enough evidence. Not enough human research to say anything useful yet.
Meta-analysis · Nutrition reviews · 2025 · PMID 39731509
Meta-analysis · BMC psychiatry · 2025 · PMID 41310510
Deep research mode adds each paper’s own conclusion and stated limitations.
Interactions, contraindications and dose limits, most serious first. Concentrated extracts interact with medication in ways the whole plant does not, so this section carries more weight here than it does on a food page.
Worth knowing
GOS is one of the oligosaccharides restricted on a low-FODMAP diet, and higher doses provoke bloating and wind in sensitive people even though tolerance is generally better than with fructans.
Allergy
Commercial GOS is manufactured from milk lactose and contains residual lactose and milk-derived material. It is unsuitable for milk allergy and may matter to people with severe lactose intolerance.
Too much
Flatulence and abdominal rumbling increase above roughly 10 g/day, as with any fermentable oligosaccharide.